Clinical Trial Update: Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma

View source ↗

Summary

A real-world study is evaluating subcutaneous epcoritamab in adults with diffuse large B-cell lymphoma and follicular lymphoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma

Drugs mentioned

• Epcoritamab (epcoritamab)

Snippet

Sponsor: AbbVie | Conditions: Diffuse Large B-cell Lymphoma, Follicular Lymphoma | Status: RECRUITING